Prescription only medicines (POMs)

Similar documents
An overview of Patient Group Directions (PGDs)

PATIENT GROUP DIRECTION. Oral (live attenuated) Typhoid Vaccine (Ty21a) (Vivotif )

PATIENT GROUP DIRECTION PROCEDURE

GG&C PGD ref no: 2016/1408 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

Policy and Procedure for the Development, Approval and Implementation of Patient Group Directions in NHS Haringey Clinical Commissioning Group

GG&C PGD ref no: 2016/1338 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

GG&C PGD ref no: 2017/1427 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

Document Details Patient Group Direction Hepatitis A vaccine (Havrix Monodose ) Trust Ref No Local Ref (optional) Main points the

Clinical Condition Indication:

Case scenarios: Patient Group Directions

This document expires on Patient Group Direction No. VI 7

Document Details. Patient Group Direction

Patient Group Directions (PGDs)

GG&C PGD ref no: 2018/1589 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

Patient Group Direction For the supply and administration of

GG&C PGD ref no: 2018/1603 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

Patient Group Direction For the supply and administration of

This document expires on Patient Group Direction No. VI 11

This document expires on Patient Group Direction No. VI 5

PATIENT GROUP DIRECTIONS POLICY

Patient Group Direction for Combined Hepatitis A & B vaccine Version: Hep A + B Start Date: 1 st January 2014 Expiry Date: 31 st December 2015

CLINICAL CONTENT OF PATIENT GROUP DIRECTION FOR PNEUMOCOCCAL CONJUGATE VACCINE (Prevenar 13 )

Patient Group Direction Hepatitis A vaccine Version: Hepatitis A 2015 Start Date: 1 st July 2015 Expiry Date:30 th June 2018

This document expires on Patient Group Direction Number VI 19

SAMPLE. PGD Reviewed by: Chris Faldon, John Maloney, Tim Patterson, Adrian MacKenzie, Claire Stein

Controlled Drugs Accountable Officers Network Scotland Executive Group. Gabapentin and Pregabalin - Frequently Asked Questions

Clinical Condition Indication:

Patient Group Direction For the supply and administration of

Patient Group Direction

Clinical Condition Indication:

Patient Group Directions Policy

Change history Version number Change details Date Updated for National ACWY programme to be implemented August June 2015.

Policy and process for development and management of PGDs for general practice that require SCCG authorisation

Patient Group Direction for Rotavirus vaccine Version: ROTAVIRUS (Rotarix ) Start Date: 1 st July 2013 Expiry Date:30 th June 2015

HEPATITIS A + TYPHOID VACCINE

NATIONAL PATIENT GROUP DIRECTION FOR SUPPLY OF PARACETAMOL ORAL SUSPENSION

Clinician Responsible for Training and Review: Emergency Department Consultant

Community Psychiatric Nurse. Consultant Psychiatrist, Substance Misuse Services

Patient Group Direction No. VI 17. Kathy Wakefield/Lisa Murray. General Practices & TRFT. Relevant Clinical Lead

CONJUGATE MENINGOCOCCAL (ACWY) VACCINE

Document Details. Patient Group Direction

Template Standard Operating Procedure For: Handling of Midazolam and other controlled drugs in Dental Practices

Chief Dental Officer England: Advice on commercial practice of online registered dental practitioners selling patient group directions for NHS

Expiry Date: September 2009 Template Version: Page 1 of 7

THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:

SAMPLE. PGD reviewed by: Dr Tim Patterson, Chris Faldon, John Maloney, Adrian Mackenzie

Patient Group Direction for Varicella vaccine Version: Varicella Start Date: 1 st April 2016 Expiry Date: 31 st March 2019

for adults engaged with the Family Wellbeing Service Isle of Wight In Community Pharmacy for Isle of Wight Public Health Commissioned Services

Document Details. Ibuprofen 200mg tablets and Ibuprofen oral liquid 100mg in 5ml

Developed By Name Signature Date

PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017

Administration of Tuberculin Purified Protein Derivative (PPD) 2TU per 0.1ml to patients attending BCG clinics with identified TB at risk factors.

Patient Group Direction for Varicella vaccine Version: Varicella Start Date: 1 st May 2014 Expiry Date: 30 th April 2017

Patient Group Direction For The Administration Of H1N1 (Swine Flu) vaccine

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Type 2 diabetes: the management of type 2 diabetes (update)

SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

Clinician Responsible for Training and Review: Emergency Department Consultant

Extension of the seasonal flu vaccination programme to children: Phase /15

DIRECT ACCESS - Guidance to BSDHT Members

Administration of Hepatitis A and B Vaccine

Patient Group Direction

by registered nurses employed by NHS Hertfordshire or Hertfordshire GP Practices and signatories to the PGD

UNSCHEDULED VACCINATION OF CHILDREN AND YOUNG PEOPLE WHO HAVE OUTSTANDING ROUTINE IMMUNISATIONS. Service Specification

PATIENT GROUP DIRECTION SUPPLY of Emergency Hormonal Contraception To females under 25 years Levonelle 1500 (Levonorgestrel 1500 micrograms)

Protocol for the Administration of Inactivated Influenza Vaccine to. Adults by Registered Nurses via Patient Specific Direction

Guidance For The Development And Implementation Of Patient Group Directions (PGDs) For Staff Working Within NHS Grampian. Consultation Group:

Patient Group Direction for SALBUTAMOL INHALER (Version 02) Valid From 1 October September 2019

PATIENT GROUP DIRECTION (PGD) Supply of potassium iodide 65mg tablets to adults and children exposed to, or at risk of exposure to radioactive iodine

South Staffordshire and Shropshire Healthcare NHS Foundation Trust

Developed By Name Signature Date

This Patient Group Direction has been developed/reviewed in accordance with NICE guidance by:- Position of Signatory Name Signed Date

PATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OR ADMINISTRATION OF LEVONORGESTREL 1500 MICROGRAM TABLET (e.g LEVONELLE 1500 ) PGD

PATIENT GROUP DIRECTION (PGD) FOR THE SUPPLY OF DOXYCYCLINE 100MG TABLETS FOR THE FIRST-LINE TREATMENT OF CHLAMYDIA TRACHOMATIS INFECTION

Patient Group Direction for GLUCAGON (Version 02) Valid From 1 October September 2019

Care Homes - Homely Remedies Protocol

Guidance for optometrist prescribers

Direction Number: - NECSAT 2014/014

Consultation Group: See relevant page in the PGD. Review Date: October 2017

COPYRIGHTED MATERIAL. Introduction

Patient Group Direction for the Administration of Haemophilus Influenzae Type b and Meningococcal C conjugated vaccine (Hib/MenC - Menitorex )

Policy for the Development and Control of Patient Group Directions (PGDs)

PGD for the administration of: Intradermal injections of Sterile Water for pain relief

Patient Group Direction for the Administration of Hepatitis A vaccine

PATIENT GROUP DIRECTION (PGD)

Patient Group Direction for the Administration of Human Papilloma Virus (HPV) Vaccine (Gardasil and Cervarix )

Safe Prescribing and Dispensing of Controlled Drugs. Joint Guidance Medical Council and Pharmaceutical Society of Ireland

Enhanced Service Specification. Childhood seasonal influenza vaccination programme 2017/18

PATIENT GROUP DIRECTION

40 Use and Supply of Drugs or Medicines in Optometric Practice

Guidance for Pharmacists on the Safe Supply of Non-Prescription Levonorgestrel 1500mcg for Emergency Hormonal Contraception

Borders. Patient Group Direction (PGD) Development Policy For NHS Borders

Putting NICE guidance into practice. Resource impact report: Hearing loss in adults: assessment and management (NG98)

Direction Number: - NECSAT 2014/003

Direction Number: - NECSAT 2014/017

Enhanced Service Specification. Childhood seasonal influenza vaccination programme 2018/19

COMPETENT AUTHORITY (UK) MEDICAL DEVICES DIRECTIVES GUIDANCE NOTES FOR MANUFACTURERS OF DENTAL APPLIANCES

Guideline scope Smoking cessation interventions and services

Reducing differences in the uptake of immunisation (PH21): Frequently asked questions for staff in Sure Start Children s Centres

Transcription:

Prescription only medicines (POMs) 2017

Learning objectives Explain the legal framework with which registered health care professionals can administer prescription only medicines Define the role and limitations of patient group directions Describe a patient specific direction and when it should be used

NMC Registrants must only supply and administer medicinal products : Patient specific direction (PSD) Patient medicines administration chart (may be called medicines administration record MAR) Patient group direction (PGD) Medicines Act exemption Standing order Prescription forms

On your tables Please discuss and identify key features of: 1. Patient Specific Direction 2. Patient Group Direction

Patient Specific Direction (PSD) A patient-specific direction (PSD) is a written instruction from a qualified and registered prescriber for a medicine including the dose, route and frequency or appliance to be supplied or administered to a named patient. In primary care, this might be a simple instruction in the patient s notes. NMC Standards for medicine management 2010

Must include Name of patient and/or other individual patient identifiers Name, form and strength of medicine (generic or brand name where appropriate) Route of administration Dose Frequency Start and finish dates. Signature of prescriber

Examples? List of patients individually assessed Written in notes Written in Personal Child Health Record (Red Book)

Delegation to HCSWs HCSWs can administer vaccines RCN has produced clear guidance on appropriate delegation to HCSWs and the questions that need to be asked (RCN website) What is your responsibility for this in your workplace?

Patient Group Directions (PGDs) Patient group directions (PGDs) are specific written instructions for the supply or administration of a licensed named medicine including vaccines to specific groups of patients who may not be individually identified before presenting for treatment.

Current legislation Current legislation for PGD s: Human Medicines Regulations 2012 Ammended in april 2013:Health & Social CareAct 2012 (consequential, transitional & saving provisions) Order 2013. no235 (i) enable Clinical Commissioning Groups, Local Authorities and the NHS Commissioning Board to authorise PGDs from April 2013; and, (Part 1, schedule 2 para 176) (ii) ensure that existing PGDs with an expiry date after 31 March 2013 will continue to be legal until the PGD either expires or is replaced. (Schedule 3 para 28)

Can be used by the following groups

PGDs can be used by NHS providers Private services funded but not provided by NHS Other private, charitable, voluntary and some crown establishments e.g. prisons

PGDs can not be used by; Independent and public sector care homes Independent sector schools outside of NHS

Authorising bodies CCGs (Clinical Commissioning Groups) Local authorities NHS trusts/foundation trusts Special health authorities NHS commissioning board

Current supply of PGDs Community trusts (School/District nursing): produced by the trust General Practice Staff: National immunisation programmes, NHS Area Team are authorising. Other imms such as some travel vaccines generally through CCG. (For some vaccines there are no PGDs)

Information to be included: name of the business the date of inception & expiry a description of the medicine(s) to which the direction applies class of health professional who may supply or administer the medicine signature of a doctor or dentist, as appropriate, and a pharmacist signature by an appropriate organisation the clinical condition or situation to which the direction applies a description of those patients excluded from treatment under the direction a description of the circumstances in which further advice should be sought from a doctor (or dentist, as appropriate) and arrangements for referral details of appropriate dosage and maximum total dosage, quantity, pharmaceutical form and strength, route and frequency of administration, and minimum or maximum period over which the medicine should be administered relevant warnings, including potential adverse reactions details of any necessary follow-up action and the circumstances; a statement of the records to be kept for audit purposes.

Process for individuals 1. Read the PGD 2. Sign the PGD 3. Work to the PGD

Off label use of vaccines Leaflets produced by PHE for: Health Care Professionals: https://www.gov.uk/government/uploads/system/uploads/attachment_d ata/file/384581/9037_offlabel_healthcare_workers_03_web.pdf Parents: https://www.gov.uk/government/uploads/system/uploads/attachment_d ata/file/384580/9037_offlabel_guide_for_parents_06_web.pdf

In pairs Please answer the following questions: What medicine is this PGD for? Which of the following patients are in the inclusion criteria? Carers, Prisoners, Pregnant women, Morbidly obese people, asthmatic not on any inhalers Can you vaccinate someone with an acute severe febrile illness? And what action should you take? When does the PGD expire?

Can supply or administration be delegated to another practitioner under a PGD? Injectable vaccine: No Non injectable medicine: if the PGD clearly only covers supply of a non-injectable medicine by the health professional named in it, then it can be given to the patient for self-administration or for administration by another person. The law requires that administration of the supplied medicine is in accordance with the PGD and so the PGD should specify that the medicine is supplied for subsequent administration http://www.medicinesresources.nhs.uk/en/communities/nhs/pgds/faqs/can-supply-oradministration-be-delegated-to-another-practitioner-under-a-pgd/

Other issues PGDs are not always reviewed when national guidance changes (e.g. MMR and egg allergy) An MMR PGD not due for review until 2014: History of confirmed anaphylactic reaction to egg containing food seek paediatric advice with a view to immunisation under controlled conditions Green Book Update January 2013: All children with egg allergy should receive the MMR vaccination as a routine procedure in primary care

Current issue with some PGDs Recent change to guidance on immunisation practice may not be reflected within current PGD e.g intervals for live vaccines when pertussis can be administered in pregnancy What should you do if patient is outside of the PGD but current guidance is clear?

On your tables Before you administering a POM what do you need to know?

Summary All vaccines are POMs and can only be administered as directed by either a PGD or PSD Legal framework for the development of PGDs NICE good practice guidelines published in August 2013 Immunisers should read and sign their PGD s PGD s should be accessible during immunisation sessions PGDs are available for Thames Valley on line at: https://www.england.nhs.uk/south/info-professional/pgd/tv/